Wakamoto Pharm FY Group Net Loss Estimate 140.00M Yen 4512 JP

Wakamoto Pharm (4512) revised full-year group earnings estimates for the period to March 31. Figures other than earnings per share are in millions of yen.

================================================================================

Operating Current Net Earnings

Revenue Profit Profit Income Per Share ================================================================================ Full-Year Estimates 9720.00 -430.00 -210.00 -140.00 -4.02 Previous Estimates 9780.00 -630.00 -480.00 -300.00 -8.62 Year-Earlier Period 9669.00 -755.00 -568.00 -425.00 -12.30 ================================================================================

Page forward for parent information...

Parent Information ================================================================================

Operating Current Net Earnings

Revenue Profit Profit Income Per Share ================================================================================ Full-Year Estimates 9700.00 -435.00 -214.00 -39.00 -1.12 Previous Estimates 9760.00 -635.00 -485.00 -200.00 -5.75 Year-Earlier Period 9629.00 -788.00 -584.00 -435.00 -12.58 ================================================================================

To contact the editor responsible for this story: Teo Chian Wei at +81-3-3201-3623 or cwteo@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.